Ellen Coleman outlines the highlights of a recent webinar on ensuring that patient advocacy is a key element of a market access strategy.
Ellen Coleman
Advertisement
Ellen Coleman (ecoleman@mkanda.com) is President and Chief Executive Officer, MK&A.
Articles by Ellen Coleman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Wegovy HD Injectable Under Accelerated Approval
2
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
3
What Are the ‘Last Mile Issues’ Impacting Pharma?
4
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
5